Dr. Ari Rosenberg, MD
Claim this profileUniversity of Chicago Comprehensive Cancer Center
Expert in Squamous Cell Carcinoma
Expert in Cancer
17 reported clinical trials
33 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Global LeaderStage IV
Stage III
PD-L1 positive
2Cancer
Global LeaderStage IV
Stage III
PD-L1 positive
Affiliated Hospitals
Clinical Trials Ari Rosenberg, MD is currently running
Radiation Therapy + Cisplatin
for Head and Neck Cancer
This trial is studying if using a specific type of energy treatment alone or with a drug is better for treating patients with advanced head and neck cancer after surgery. The energy treatment kills cancer cells, and the drug helps by stopping their growth or killing them. The drug has been used for many years in the treatment of advanced cancers, including head and neck cancers, and is known for its ability to enhance the effects of the energy treatment.
Recruiting1 award Phase 219 criteria
Immunotherapy +/− Targeted Therapy
for Nasopharyngeal Cancer
This phase II trial tests how well nivolumab and ipilimumab immunotherapy with or without cabozantinib works in treating patients with nasopharyngeal cancer that has come back (after a period of improvement) (recurrent), has spread from where it first started (primary site) to other places in the body (metastatic), or for which no treatment is currently available (incurable). Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cabozantinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells. Giving immunotherapy with nivolumab and ipilimumab and targeted therapy with cabozantinib may help shrink and stabilize nasopharyngeal cancer.
Recruiting1 award Phase 2
More about Ari Rosenberg, MD
Clinical Trial Related6 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Ari Rosenberg, MD has experience with
- Carboplatin
- Paclitaxel
- Pembrolizumab
- Cetuximab
- Cisplatin
- Nivolumab
Breakdown of trials Ari Rosenberg, MD has run
Squamous Cell Carcinoma
Cancer
Head and Neck Cancers
Throat Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ari Rosenberg, MD specialize in?
Ari Rosenberg, MD focuses on Squamous Cell Carcinoma and Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are Stage III.
Is Ari Rosenberg, MD currently recruiting for clinical trials?
Yes, Ari Rosenberg, MD is currently recruiting for 11 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Ari Rosenberg, MD has studied deeply?
Yes, Ari Rosenberg, MD has studied treatments such as Carboplatin, Paclitaxel, Pembrolizumab.
What is the best way to schedule an appointment with Ari Rosenberg, MD?
Apply for one of the trials that Ari Rosenberg, MD is conducting.
What is the office address of Ari Rosenberg, MD?
The office of Ari Rosenberg, MD is located at: University of Chicago Comprehensive Cancer Center, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.